Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Immunotherapy
  • Page 2

Tag: Immunotherapy

  • Biotechnopedia
  • DNA-Tales

Cancelling Cancer: Decoding cells for Immunotherapy

bioxone December 7, 2020December 7, 2020 1

Milanckona Das, Amity University Kolkata The desire to eliminate cancer permanently has remained an unattainable feat for scientists to this day. Although difficult to realize, it is a fact that our bodies continually deal with cancer on a minuscule level, daily. Immunotherapy is typically associated with cancer treatment, to effectively cause the cancellation of long-lasting […]

Read More
  • Biotechnopedia
  • DNA-Tales

CAR-T FOR CARCINOMA- THE GAME CHANGER IN CANCER TREATMENT

bioxone November 23, 2020November 23, 2020 1

PRIASHA DUTTA, AMITY UNIVERSITY KOLKATA, WEST BENGAL One of the leading causes of mortality in the present-day world is cancer. Whenever we think of cancer treatment, the two words that are immediately synonymous are chemotherapy and radiation therapy. Although, due to limited efficacy based on the heterogeneity factor of cancer cells, there is a constant […]

Read More
  • BiotechToday
  • World

Regulatory expression of Co-inhibitory receptors by Type 1 Interferon transcriptional network in human T cells

bioxone November 2, 2020November 2, 2020 1

Rohit Bhattacharjee, Amity University Kolkata Although inhibition of T cell co-inhibitory receptors has brought about cancer therapy, mechanisms governing their expression on human T cells have not been explained. Type 1 interferon (IFN-I) regulates T cell immunity in viral infection, autoimmunity, cancer, and may enhance induction of T cell exhaustion in chronic viral infection. To […]

Read More
  • BiotechToday
  • World

Structural and Functional Inhibition of CHIKV by CHK-124 and CHK-263mAbs

bioxone October 24, 2020October 23, 2020

Souradip Mallick, National Institute of Technology, Rourkela Chikungunya fever is a self-remitting viral illness that is common in tropical countries like Africa and Southeast Asia caused by the Chikungunya virus (CHIKV) (Genus- alphavirus, Family-Togaviridae), single-stranded positive-sense RNA enveloped virus, transmitted to humans by infected Aedes aegypti and Aedes albopictus mosquitoes. International travel is one of the […]

Read More
  • BiotechToday
  • World

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

bioxone October 21, 2020October 21, 2020

Binayak Das, Team Bioxone A study conducted to unravel the potential of immunotherapy for patients affected by the covid-19 virus has announced that treatment with intravenous-immunoglobulin can potentially benefit covid-19 patients that are severely affected. Intravenous immunoglobulin or IVIG is the collection of IgG obtained from the blood serum of a large number of healthy […]

Read More
  • BiotechToday
  • World

Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

bioxone October 21, 2020October 21, 2020

Chitra Roy, University of Calcutta Cancer Immunotherapy work by helping the immune system to function in an efficient manner to fight cancer cells. For the immune system to start its response, it must first be able to identify and differentiate between self-part of your own body and non-self-foreign/antigen. Cancer Immunotherapy is generally divided in two […]

Read More
  • BiotechToday
  • World

Researches discover how more than a hundred genes assist cancer in evasion of the immune system

bioxone September 26, 2020September 26, 2020

Sayak Banerjee, Amity University Kolkata Immunotherapy, although being a formidable cancer treatment, produces durable responses for a few tumor types only. Lately, scientists have identified 182 genes that enable the cancer cells to evade death by the immune system. They carried out genome-wide CRISPR screens across a group of genetically varying mouse cancer cell lines, […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy